- Titre
- Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal"
- Créateurs - sans rôle
- Andreas Meisel - Department of Neurology, Integrated Myasthenia Gravis Center, NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, GermanyFulvio Baggi - Neuroimmunology and Neuromuscular Diseases Unit, Scientific Institute for Research and Health Care Foundation Carlo Besta Neurological Institute, Milan, ItalyAnthony Behin - Pitié-Salpêtrière HospitalAmelia Evoli - Scientific Institute for Research and Health Care, Catholic University of the Sacred Heart and Agostino Gemelli University Polyclinic Foundation, Rome, ItalyAnna Kostera-Pruszczyk - Department of Neurology, Medical University of Warsaw, Warsaw, PolandRenato Mantegazza - Neuroimmunology and Neuromuscular Diseases Unit, Scientific Institute for Research and Health Care Foundation Carlo Besta Neurological Institute, Milan, ItalyRaul Juntas Morales - Neurology Department, Vall d'Hebron University Hospital, Barcelona, SpainAnna Rostedt Punga - Department of Medical Science, Clinical Neurophysiology, Uppsala University, Uppsala, SwedenSabrina Sacconi - Nice University Hospital Center, Nice, FranceMichael Schroeter - Department of Neurology, University Hospital Cologne, Cologne, GermanyJan Verschuuren - Neurology, Leiden University Medical Center, Leiden, the NetherlandsLouise Crathorne - Prescript Communications, Letchworth, UKKris Holmes - Prescript Communications, Letchworth, UKMaria-Isabel Leite - Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
- Détails de publication
- European journal of neurology, Vol.30(4), pp.1162-1164
- Identifiants
- 99155014609311
- Unité académique
- Institut des Neurosciences de Montpellier - INM
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal"
European journal of neurology, Vol.30(4), pp.1162-1164
04/2023
PMID: 36692238
Indicateurs
1 Consultations de la notice